Literature DB >> 2722440

The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye.

R Braakman1, P van der Valk, J L van Delft, D de Wolff-Rouendaal, J A Oosterhuis.   

Abstract

Greene's melanomas, implanted in the anterior chamber of 31 eyes of 19 Dutch rabbits, were treated with hyperthermia induced by high intensity focused ultrasound (HIFU). The percentage necrosis 24 hr after treatment (N) as a function of steady-state intratumor temperature (T) could be described with N(T) = -181.5 + 4.7T (P less than 0.05). The most frequent side effect was a local hemorrhagic keratitis. The acoustic absorption coefficient and thermal conductivity of the tumor tissue were 0.08 cm-1 X MHz-1 at 36 degrees C and 0.011 W, cm-1 X degrees C-1, respectively. With these parameters a simple thermal model was established that enabled us to predict the ultrasonic intensity needed to reach a desired intratumor temperature.

Entities:  

Mesh:

Year:  1989        PMID: 2722440

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Histopathological findings in human choroidal melanomas after transpupillary thermotherapy.

Authors:  J G Journée-de Korver; J A Oosterhuis; D de Wolff-Rouendaal; H Kemme
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

3.  Microwave plaque thermoradiotherapy for choroidal melanoma.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

Review 4.  Xenon arch photocoagulator used for transpupillary hyperthermia.

Authors:  J G Journée-de Korver; J A Oosterhuis; J A van Best; J Fakkel
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

5.  Hamster Greene melanoma in the rabbit eye: immunosuppressive treatment to improve this tumor model.

Authors:  I de Waard-Siebinga; J L van Delft; D de Wolff-Rouendaal; M Jager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-11       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.